International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder

被引：96

作者：

Crunelle, Cleo L. ^{[1
,2
]}

van den Brink, Wim ^{[3
]}

Moggi, Franz ^{[4
]}

Konstenius, Maija ^{[5
]}

Franck, Johan ^{[5
]}

Levin, Frances R. ^{[6
]}

van de Glind, Geurt ^{[7
]}

Demetrovics, Zsolt ^{[8
]}

Coetzee, Corne ^{[9
]}

Luderer, Mathias ^{[10
]}

Schellekens, Arnt ^{[11
]}

Matthys, Frieda ^{[1
]}

机构：

[1] Univ Ziekenhuis Brussel UZ Brussel, Vrije Univ Brussel, Dept Psychiat, Brussels, Belgium

[2] Antwerp Univ, Toxicol Ctr, Antwerp, Belgium

[3] Univ Amsterdam, Acad Med Ctr, AIAR, Amsterdam, Netherlands

[4] Univ Bern, Univ Hosp Psychiat, Bern, Switzerland

[5] Karolinska Inst, Stockholm, Sweden

[6] Columbia Univ, New York State Psychiat Inst, New York, NY USA

[7] Univ Amsterdam, ICASA Fdn, Amsterdam, Netherlands

[8] Eotvos Lorand Univ, Budapest, Hungary

[9] Univ Limpopo, Dept Pharm, Sovenga, South Africa

[10] Heidelberg Univ, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, Med Fac Mannheim, Heidelberg, Germany

[11] Radboudumc, Dept Psychiat, Donders Inst Brain Cognit & Behav, NISPA, Nijmegen, Netherlands

来源：

EUROPEAN ADDICTION RESEARCH | 2018年 / 24卷 / 01期

关键词：

Attention deficit/hyperactivity disorder; Substance use disorders; Diagnosis; Treatment; Consensus; DEFICIT HYPERACTIVITY DISORDER; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; SELF-REPORT SCALE; ADULT ADHD; TREATMENT-SEEKING; DOUBLE-BLIND; NONMEDICAL USE; METHYLPHENIDATE;

D O I：

10.1159/000487767

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (SUD) and is associated with early onset and more severe development of SUD and with reduced treatment effectiveness. Screening tools allow for a good recognition of possible ADHD in adults with SUD and should be used routinely, followed by an ADHD diagnostic process initiated as soon as possible. Simultaneous and integrated treatment of ADHD and SUD, using a combination of pharmaco- and psychotherapy, is recommended. Long-acting methylphenidate, extended-release amphetamines, and atomoxetine with up-titration to higher dosages may be considered in patients unresponsive to standard doses. This paper includes evidence- and consensus-based recommendations developed to provide guidance in the screening, diagnosis and treatment of patients with ADHD-SUD comorbidity. (c) 2018 S. Karger AG, Basel

引用

页码：43 / 51

页数：9

共 50 条

[21] Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders
Simon, Nicolas
Rolland, Benjamin
Karila, Laurent
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (23) : 3359 - 3366
[22] Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test
Slobodin, Ortal
Blankers, Matthijs
Kapitany-Foveny, Mate
Kaye, Sharlene
Berger, Itai
Johnsoni, Brian
Demetrovics, Zsolt
van den Brink, Wim
van de Glind, Geurt
EUROPEAN ADDICTION RESEARCH, 2020, 26 (03) : 151 - 161
[23] Comorbid Attention-Deficit/Hyperactivity Disorder and Mood Disorder in a South African Sample of Substance Use Disorder Patients
Truter, Ilse
Regnart, Judith
Meyer, Anneke
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
[24] The intersection of attention-deficit/hyperactivity disorder and substance abuse
Wilens, Timothy E.
Morrison, Nicholas R.
CURRENT OPINION IN PSYCHIATRY, 2011, 24 (04) : 280 - 285
[25] Prevalence of attention-deficit hyperactivity disorder in substance addiction: from screening to diagnosis
Pedrero-Perez, Eduardo J.
Ruiz-Sanchez de Leon, Jose M.
Rojo-Mota, Gloria
Llanero-Luque, Marcos
Puerta-Garcia, Carmen
REVISTA DE NEUROLOGIA, 2011, 52 (06) : 331 - 340
[26] The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study
Brynte, Christoffer
Aeschlimann, Myriam
Barta, Csaba
Begeman, Alex Hendikus Abraham
Backer, Amanda
Crunelle, Cleo Lina
Daigre, Constanza
De Fuentes-Merillas, Laura
Demetrovics, Zsolt
Dom, Geert
Grau Lopez, Lara
Icick, Romain
Johnson, Brian
Joostens, Peter
Kapitany-Foveny, Mate
Karsinti, Emily
Kiefer, Falk
Konstenius, Maija
Levin, Frances R.
Luderer, Mathias
Markus, Wiebren
Matthys, Frieda
Moggi, Franz
Felipe Palma-Alvarez, Raul
Paraskevopoulou, Maria
Antoni Ramos-Quiroga, J.
Schellekens, Arnt
Soravia, Leila M.
Therribout, Norman
Thomas, Anil
van de Glind, Geurt
van Kernebeek, Michiel Willem
Vollstaedt-Klein, Sabine
Vorspan, Florence
van den Brink, Wim
Franck, Johan
BMC PSYCHIATRY, 2022, 22 (01)
[27] Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults
Young, Jesse Tyler
Carruthers, Susan
Kaye, Sharlene
Allsop, Steve
Gilsenan, Joanne
Degenhardt, Louisa
van de Glind, Geurt
van den Brink, Wim
Preen, David
DRUG AND ALCOHOL REVIEW, 2015, 34 (06) : 683 - 693
[28] Attention-Deficit/Hyperactivity Disorder Subtypes in Adolescents with Comorbid Substance-Use Disorder
Tamm, Leanne
Adinoff, Bryon
Nakonezny, Paul A.
Winhusen, Theresa
Riggs, Paula
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2012, 38 (01) : 93 - 100
[29] National Institutes of Health Consensus Development Conference Statement: Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)
Kupfer, DJ
Baltimore, RS
Berry, DA
Breslau, N
Ellinwood, EH
Ferre, J
Ferriero, DM
Fuchs, LS
Guze, SB
Hamburg, BA
McGlothlin, J
Turner, SM
Vonnegut, M
Abikoff, H
Anderson, S
Arnold, LE
Barkley, RA
Biederman, J
Bird, HR
Breggin, PR
Carey, WB
Chemers, B
Conners, CK
Cooper, JR
Danielson, L
Feussner, G
Forness, SR
Greenhill, LL
Hinshaw, SP
Hoagwood, K
Jensen, PS
Johnston, C
Kalivas, PW
Kelleher, KJ
Klein, RG
Lahey, BB
Lambert, NM
Loney, J
Pelham, WE
Rowland, AS
Swanson, J
Tannock, R
Wilens, TE
Wolraich, ML
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2000, 39 (02) : 182 - 193
[30] Adult Attention Deficit/Hyperactivity Disorder, Associated Symptoms and Comorbid Psychiatric Disorders: Diagnosis and Pharmacological Treatment
Paslakis, G.
Schredl, M.
Alm, B.
Sobanski, E.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2013, 81 (08) : 444 - 451

← 1 2 3 4 5 →